Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Tissue factor pathway inhibitor (TFPI) is a key regulator of the extrinsic coagulation pathway.
• TFPI inhibits factor Xa directly and the factor VIIa/tissue factor complex in a factor Xa-dependent manner.

Purpose of the Study:

• To investigate the structure-function relationship of TFPI, specifically the role of its C-terminus in inhibitory activity and heparin binding.
• To characterize altered forms of recombinant TFPI (rTFPI) and their interactions with coagulation factors and cofactors.

Main Methods:

• Utilized sequential deletions of the C-terminus of TFPI to create altered recombinant proteins.
• Assessed the inhibitory activity of rTFPI variants against factor Xa and Gla-domainless factor Xa.
• Investigated the binding affinity of rTFPI to heparin-agarose under varying ionic strengths.
• Examined the effects of calcium ions (Ca2+), heparin, phospholipids, and factor Va on TFPI's inhibitory function.

Main Results:

• Sequential C-terminal deletions of TFPI progressively reduced its inhibitory activity against factor Xa and its affinity for heparin.
• Deletion of the third Kunitz-type domain resulted in loss of heparin binding at physiological ionic strength.
• A specific region (residues 230-241) within the third Kunitz domain, rich in positively charged residues, is implicated in heparin binding.
• Heparin and Ca2+ synergistically enhanced the rate of factor Xa inhibition by full-length TFPI, suggesting a template mechanism.

Conclusions:

• The C-terminus of TFPI, including the third Kunitz-type domain, is essential for both factor Xa inhibition and heparin binding.
• Heparin and Ca2+ play critical roles in potentiating TFPI's anticoagulant activity through a likely template-mediated mechanism.
• Understanding these interactions is vital for developing targeted anticoagulant therapies.